Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

NCT07638332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemorrhagic Cystitis

Interventions

BIOLOGICAL: LB-DTK-BKV
OTHER: Standard-of-care

Sponsor

LucasBio